Eva Stefanski

1.4k total citations
24 papers, 1.1k citations indexed

About

Eva Stefanski is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Eva Stefanski has authored 24 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Pharmacology and 6 papers in Oncology. Recurrent topics in Eva Stefanski's work include Protein Kinase Regulation and GTPase Signaling (7 papers), Venomous Animal Envenomation and Studies (5 papers) and Immune Response and Inflammation (4 papers). Eva Stefanski is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (7 papers), Venomous Animal Envenomation and Studies (5 papers) and Immune Response and Inflammation (4 papers). Eva Stefanski collaborates with scholars based in Canada, United States and France. Eva Stefanski's co-authors include Peter Vadas, W. Pruzanski, Berit Sternby, Norbert Degousée, Barry B. Rubin, Thomas F. Lindsay, Brian P. Kennedy, H. van den Bosch, Robert A. Greenwald and Gérard Lambeau and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Circulation Research.

In The Last Decade

Eva Stefanski

24 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Stefanski Canada 19 474 193 179 150 144 24 1.1k
Stanley J. Wertheimer United States 12 449 0.9× 108 0.6× 228 1.3× 81 0.5× 99 0.7× 19 888
H.A. Leaver United Kingdom 20 335 0.7× 107 0.6× 165 0.9× 99 0.7× 56 0.4× 61 1.1k
Kalathur S. Ramanujam United States 14 262 0.6× 278 1.4× 116 0.6× 189 1.3× 130 0.9× 17 989
Monika Ermert Germany 17 219 0.5× 171 0.9× 279 1.6× 73 0.5× 210 1.5× 21 1.2k
E. Stefanski Canada 16 396 0.8× 95 0.5× 117 0.7× 135 0.9× 93 0.6× 27 797
Diane M Spencer United States 15 712 1.5× 104 0.5× 229 1.3× 94 0.6× 179 1.2× 24 1.2k
Jennifer L. Goulet United States 13 289 0.6× 356 1.8× 220 1.2× 142 0.9× 264 1.8× 15 923
A. Maria Olofsson United States 12 357 0.8× 62 0.3× 232 1.3× 67 0.4× 90 0.6× 14 1.1k
J. D. Lutton United States 22 859 1.8× 109 0.6× 259 1.4× 202 1.3× 287 2.0× 69 1.8k
LM Pelus United States 9 317 0.7× 265 1.4× 349 1.9× 106 0.7× 116 0.8× 14 1.0k

Countries citing papers authored by Eva Stefanski

Since Specialization
Citations

This map shows the geographic impact of Eva Stefanski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Stefanski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Stefanski more than expected).

Fields of papers citing papers by Eva Stefanski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Stefanski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Stefanski. The network helps show where Eva Stefanski may publish in the future.

Co-authorship network of co-authors of Eva Stefanski

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Stefanski. A scholar is included among the top collaborators of Eva Stefanski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Stefanski. Eva Stefanski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kelvin, Alyson A., Norbert Degousée, David W. Banner, et al.. (2014). Lack of group X secreted phospholipase A2 increases survival following pandemic H1N1 influenza infection. Virology. 454-455. 78–92. 19 indexed citations
2.
Degousée, Norbert, David J. Kelvin, Gerd Geißlinger, et al.. (2011). Group V Phospholipase A2 in Bone Marrow-derived Myeloid Cells and Bronchial Epithelial Cells Promotes Bacterial Clearance after Escherichia coli Pneumonia. Journal of Biological Chemistry. 286(41). 35650–35662. 21 indexed citations
3.
Degousée, Norbert, Denis Angoulvant, Shafie Fazel, et al.. (2006). c-Jun N-terminal Kinase-mediated Stabilization of Microsomal Prostaglandin E2 Synthase-1 mRNA Regulates Delayed Microsomal Prostaglandin E2 Synthase-1 Expression and Prostaglandin E2 Biosynthesis by Cardiomyocytes. Journal of Biological Chemistry. 281(24). 16443–16452. 27 indexed citations
4.
Degousée, Norbert, Joshua J. Martindale, Eva Stefanski, et al.. (2003). MAP Kinase Kinase 6–p38 MAP Kinase Signaling Cascade Regulates Cyclooxygenase-2 Expression in Cardiac Myocytes In Vitro and In Vivo. Circulation Research. 92(7). 757–764. 40 indexed citations
5.
Degousée, Norbert, Farideh Ghomashchi, Eva Stefanski, et al.. (2002). Groups IV, V, and X Phospholipases A2s in Human Neutrophils. Journal of Biological Chemistry. 277(7). 5061–5073. 165 indexed citations
6.
Pruzanski, W., et al.. (2001). Mitogenic Effect of Lipoproteins on Human Vascular Smooth Muscle Cells: The Impact of Hydrolysis by gr II A Phospholipase A2. Laboratory Investigation. 81(5). 757–765. 13 indexed citations
7.
Degousée, Norbert, Eva Stefanski, Thomas F. Lindsay, et al.. (2001). p38 MAPK Regulates Group IIa Phospholipase A2Expression in Interleukin-1β-stimulated Rat Neonatal Cardiomyocytes. Journal of Biological Chemistry. 276(47). 43842–43849. 18 indexed citations
8.
Katz, Alan, H. van den Bosch, Brian P. Kennedy, et al.. (1998). Induction of Secretory Phospholipase A2 Confirms the Systemic Inflammatory Nature of Adjuvant Arthritis. Inflammation. 22(2). 161–173. 7 indexed citations
9.
Pruzanski, W., Eva Stefanski, Peter Vadas, Brian P. Kennedy, & H. van den Bosch. (1998). Regulation of the cellular expression of secretory and cytosolic phospholipases A2, and cyclooxygenase-2 by peptide growth factors. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1403(1). 47–56. 55 indexed citations
10.
Pruzanski, W., Eva Stefanski, Frederick C. de Beer, et al.. (1998). Lipoproteins are substrates for human secretory group IIA phospholipase A2: preferential hydrolysis of acute phase HDL. Journal of Lipid Research. 39(11). 2150–2160. 78 indexed citations
11.
Pruzanski, W., Eva Stefanski, Peter Vadas, & Nungavaram S. Ramamurthy. (1997). Inhibition of extracellular release of proinflammatory secretory phospholipase A2 (sPLA2) by sulfasalazine. Biochemical Pharmacology. 53(12). 1901–1907. 45 indexed citations
12.
Vadas, Peter, Eva Stefanski, Marek Wloch, et al.. (1996). Secretory Non‐Pancreatic Phospholipase A2 and cyclooxygenase‐2 Expression by Tracheobronchial Smooth Muscle Cells. European Journal of Biochemistry. 235(3). 557–563. 38 indexed citations
13.
Vadas, Peter, Eva Stefanski, Brigitte Grouix, Bastiaan Schouten, & W. Pruzanski. (1995). Inhibition of human group II phospholipase A2 by C-reactive protein in vitro. PubMed. 11(2). 187–200. 6 indexed citations
14.
Vadas, Peter, L. Chimsuku, J. P. Dean Goldring, et al.. (1993). Increased Serum Phospholipase A2 Activity in Malawian Children with Falciparum Malaria. American Journal of Tropical Medicine and Hygiene. 49(4). 455–459. 22 indexed citations
15.
Vadas, Peter, Bastiaan Schouten, Eva Stefanski, Kieran F. Scott, & W. Pruzanski. (1993). Association of hyperphospholipasemia A2 with multiple system organ dysfunction due to salicylate intoxication. Critical Care Medicine. 21(7). 1087–1091. 18 indexed citations
16.
Pruzanski, W., et al.. (1992). Inhibition of enzymatic activity of phospholipases A2 by minocycline and doxycycline. Biochemical Pharmacology. 44(6). 1165–1170. 99 indexed citations
17.
Vadas, Peter, et al.. (1991). Extracellular phospholipase A2 secretion is a common effector pathway of interleukin-1 and tumour necrosis factor action. Immunology Letters. 28(3). 187–193. 50 indexed citations
18.
19.
Seilhamer, Jeffrey J., W. Pruzanski, J. S. Schilling, et al.. (1989). Multiple Forms of Phospholipase A2 in Arthritic Synovial Fluid. The Journal of Biochemistry. 106(1). 38–42. 54 indexed citations
20.
Vadas, Peter, Eva Stefanski, Berit Sternby, et al.. (1988). Pathogenesis of hypotension in septic shock. Critical Care Medicine. 16(1). 1–7. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stanley J. Wertheimer Breakdown of academic impact, for papers by H.A. Leaver Breakdown of academic impact, for papers by Kalathur S. Ramanujam Breakdown of academic impact, for papers by Monika Ermert Breakdown of academic impact, for papers by E. Stefanski Breakdown of academic impact, for papers by Diane M Spencer Breakdown of academic impact, for papers by Jennifer L. Goulet Breakdown of academic impact, for papers by A. Maria Olofsson Breakdown of academic impact, for papers by J. D. Lutton Breakdown of academic impact, for papers by LM Pelus
Rankless by CCL
2026